CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis

CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis

This consensus document was developed by an international panel of experts on neurofilament biomarker research and clinical applications in MS, in partnership with the Consortium of Multiple Sclerosis Centers (CMSC). The panelists met in two virtual consensus conferences held on September 3, 2020 and October 16, 2020 to comprehensively review available data, determine practical applications of the data for MS, and debate conflicting information and unanswered questions.

Download the consensus document
admin

Comments are closed.

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last